TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34590981

Group type: EXPERIMENTAL
Intervention: W-shaped incision
Number of subjects: 61

Group type: COMPARATOR
Intervention: Tear trough incision
Number of subjects: 61
Study: 36055535

Group type: EXPERIMENTAL
Intervention: Bilateral stimulation (BS)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Unilateral stimulation (US)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Sham (Control)
Number of subjects: 61
Study: 33885203

Group type: EXPERIMENTAL
Intervention: Varenicline (1 mg twice daily)
Number of subjects: 8144

Group type: EXPERIMENTAL
Intervention: Bupropion (150 mg twice daily)
Number of subjects: 8144

Group type: EXPERIMENTAL
Intervention: Nicotine patch (21 mg once daily with taper)
Number of subjects: 8144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8144
Study: 34010807

Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg/kg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (no supplementation)
Number of subjects: 36
Study: 33099015

Group type: COMPARATOR
Intervention: Lifestyle intervention focusing on age-appropriate infant physical activation, healthy sleep and sedentary patterns, and response feeding, delivered through technology and phone counseling.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 0
Study: 36094451

Group type: EXPERIMENTAL
Intervention: 2% CO2
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 4% CO2
Number of subjects: 12

Group type: COMPARATOR
Intervention: 0% CO2
Number of subjects: 12
Study: 32703758

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Kaleidoscope usage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hand massage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postoperative vomiting and nausea
Number of subjects: 0
Study: 34776423

Group type: EXPERIMENTAL
Intervention: Physiotherapy intervention (16 sessions of 60 minutes each over 8 weeks)
Number of subjects: 24
Study: 36313402

Group type: EXPERIMENTAL
Intervention: High-Intensity Laser Therapy (HILT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sham Laser (Control)
Number of subjects: 42
Study: 32310273

Group type: EXPERIMENTAL
Intervention: Pitavastatin therapy in PWH
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Pitavastatin therapy in non-HIV participants
Number of subjects: 135
Study: 35422024

Group type: EXPERIMENTAL
Intervention: Bisoprolol (1.25 mg tablets, titrated up to a maximum of 5 mg daily over 4-7 weeks)
Number of subjects: 1574

Group type: COMPARATOR
Intervention: Placebo (identical to bisoprolol)
Number of subjects: 1574
Study: 33475735

Group type: EXPERIMENTAL
Intervention: Svo2-guided transfusion
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (standard transfusion strategy)
Number of subjects: 100
Study: 32920205

Group type: EXPERIMENTAL
Intervention: PTCy/tacrolimus/mycophenolate mofetil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tacrolimus/methotrexate
Number of subjects: 0
Study: 34847402

Group type: EXPERIMENTAL
Intervention: Mobile-based tailored intervention (three sessions with 27 tailored messages)
Number of subjects: 21
Study: 32996893

Group type: EXPERIMENTAL
Intervention: MyDiabetesPlan (intervention group, n=111)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Control (static generic Diabetes Canada resources, control group, n=102)
Number of subjects: 213
Study: 34275697

Group type: EXPERIMENTAL
Intervention: De-escalation therapy
Number of subjects: 55798

Group type: COMPARATOR
Intervention: De-escalation to clopidogrel or low-dose prasugrel
Number of subjects: 55798
Study: 34999696

Group type: EXPERIMENTAL
Intervention: Routine identification of recurrent laryngeal nerve (Group A)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Non-identification of recurrent laryngeal nerve (Group B)
Number of subjects: 300
Study: 32199717

Group type: EXPERIMENTAL
Intervention: Bilateral inferior alveolar nerve block (BIANB)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Standard protocol (control)
Number of subjects: 51
Study: 33509043

Group type: EXPERIMENTAL
Intervention: del Nido cardioplegia
Number of subjects: 90

Group type: COMPARATOR
Intervention: St. Thomas solution
Number of subjects: 90
Study: 32350749

Group type: EXPERIMENTAL
Intervention: Cannabidiol (20 mg/kg/day)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 35291966

Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy (SCRT) combined with 6 cycles of capecitabine plus oxaliplatin (CAPOX) and Toripalimab (Consolidation arm)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: 2 cycles of CAPOX and Toripalimab followed by SCRT and then 4 cycles of CAPOX and Toripalimab (Induction arm)
Number of subjects: 130
Study: 32966832

Group type: EXPERIMENTAL
Intervention: Sonodynamic therapy (SDT)
Number of subjects: 32
Study: 35561480

Group type: EXPERIMENTAL
Intervention: Zinc gluconate (30 mg/day elemental zinc)
Number of subjects: 50
Study: 33130281

Group type: EXPERIMENTAL
Intervention: Scalp pH
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Scalp lactates
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Severe acidosis at birth (cord pH < 7.00)
Number of subjects: 268
Study: 32888200

Group type: EXPERIMENTAL
Intervention: Immortalized F2 (IF2) population of Undaria pinnatifida
Number of subjects: 520
Study: 35918587

Group type: EXPERIMENTAL
Intervention: Oniria® (1.98 mg prolonged-release melatonin)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Immediate-release tablets (IRT)
Number of subjects: 14
Study: 33798305

Group type: EXPERIMENTAL
Intervention: Interactive scalp acupuncture
Number of subjects: 660

Group type: COMPARATOR
Intervention: Scalp acupuncture
Number of subjects: 660

Group type: COMPARATOR
Intervention: Scalp acupuncture plus cognitive training
Number of subjects: 660
Study: 35200576

Group type: EXPERIMENTAL
Intervention: Exercise intervention (EX)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waitlist control (WT)
Number of subjects: 60
Study: 34163127

Group type: EXPERIMENTAL
Intervention: ISVCZ 50ug/0.1 mL
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ISAMB 5ug/0.1 mL
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ISNTM 10ug/0.1 mL
Number of subjects: 60
Study: 33210345

Group type: EXPERIMENTAL
Intervention: Patient navigation intervention
Number of subjects: 134

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 134
Study: 33017213

Group type: EXPERIMENTAL
Intervention: Postoperative atrial fibrillation (pAF)
Number of subjects: 3023

Group type: COMPARATOR
Intervention: Sinus rhythm (control group)
Number of subjects: 3023
Study: 34752681

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT) with maintenance antidepressant medication (mADM)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT) with discontinued maintenance antidepressant medication (mADM)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT) with continued maintenance antidepressant medication (mADM)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 282
Study: 33743108

Group type: EXPERIMENTAL
Intervention: DArT method (dance-physiotherapy combined intervention)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 38
Study: 33757137

Group type: EXPERIMENTAL
Intervention: Increased nasal flow therapy (8-10 L/min)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Standard nasal flow therapy (5-7 L/min)
Number of subjects: 212
Study: 33942801

Group type: EXPERIMENTAL
Intervention: Increased TSH levels
Number of subjects: 726986

Group type: EXPERIMENTAL
Intervention: FT3:FT4 ratio
Number of subjects: 726986

Group type: EXPERIMENTAL
Intervention: Genetically predicted FT4 and TPOAb
Number of subjects: 726986
Study: 35590031

Group type: EXPERIMENTAL
Intervention: PROERD program (10 classes delivered by trained police officers)
Number of subjects: 4030

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 4030
Study: 33857850

Group type: EXPERIMENTAL
Intervention: Fushen Granule (FSG)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Probiotics (PRO)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 42
Study: 33464760

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine with 1:200,000 epinephrine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1% ropivacaine
Number of subjects: 60
Study: 86299308

Group type: EXPERIMENTAL
Intervention: 16 standard marijuana cigarettes (2.8% Delta‐9‐THC)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: 4 standard marijuana cigarettes (2.8% Delta‐9‐THC)
Number of subjects: 5
Study: 35438535

Group type: EXPERIMENTAL
Intervention: Nx4
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 33556551

Group type: EXPERIMENTAL
Intervention: Long head of biceps tenotomy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Suprapectoral long head of biceps tenodesis
Number of subjects: 100

Group type: COMPARATOR
Intervention: Long head of biceps tenodesis
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 100
Study: 32212817

Group type: EXPERIMENTAL
Intervention: Health education program including educational talk, demo video, experience sharing, pamphlet distribution, and text message reminders.
Number of subjects: 210

Group type: COMPARATOR
Intervention: Educational talk alone (Control group).
Number of subjects: 210
Study: 35030133

Group type: EXPERIMENTAL
Intervention: Intraoperative intravenous bolus dose of Dexmedetomidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34247889

Group type: EXPERIMENTAL
Intervention: Implantable cardiac monitor (ICM)
Number of subjects: 334
Study: 36100300

Group type: EXPERIMENTAL
Intervention: Above-average continuity
Number of subjects: 173993

Group type: EXPERIMENTAL
Intervention: Perfect continuity
Number of subjects: 173993

Group type: COMPARATOR
Intervention: Average continuity
Number of subjects: 173993
Study: 34763475

Group type: EXPERIMENTAL
Intervention: Simplified dressing change
Number of subjects: 76

Group type: COMPARATOR
Intervention: Traditional debridement and dressing change
Number of subjects: 76
Study: 32628115

Group type: EXPERIMENTAL
Intervention: Adaptive feedback
Number of subjects: 572

Group type: COMPARATOR
Intervention: Standardized feedback
Number of subjects: 572

Group type: EXPERIMENTAL
Intervention: Adaptive feedback with immediate repetition
Number of subjects: 572

Group type: EXPERIMENTAL
Intervention: Adaptive feedback after a week
Number of subjects: 572

Group type: EXPERIMENTAL
Intervention: Both feedback forms
Number of subjects: 572
Study: 36193094

Group type: EXPERIMENTAL
Intervention: L. crispatus G14‐5M (2 g twice daily for one month)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: L. helveticus M2‐09‐R02‐S146 (2 g twice daily for one month)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: L. plantarum CCFM8610 (2 g twice daily for one month)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Lactobacillus strains (all three)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: None of the Lactobacillus strains
Number of subjects: 78
Study: 33341950

Group type: EXPERIMENTAL
Intervention: Health information via a tablet computer plus 10 live health coaching sessions delivered virtually (intervention group; n=125)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Health information via a tablet only (control group; n=125)
Number of subjects: 250
Study: 36447142

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) injected on embryo transfer day
Number of subjects: 100

Group type: COMPARATOR
Intervention: Human chorionic gonadotropin (HCG) injected on embryo transfer day
Number of subjects: 100
Study: 32498771

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) intervention using 'Bear Blast' game module displayed on Samsung Gear Oculus VR headset
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tablet-based control intervention with comparable audio, visual, and tactile components
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) intervention
Number of subjects: 20
Study: 35219908

Group type: EXPERIMENTAL
Intervention: Mycosinate®
Number of subjects: 38

Group type: COMPARATOR
Intervention: 5% Amorolfine
Number of subjects: 38
Study: 33184830

Group type: COMPARATOR
Intervention: Early cord clamping (ECC) (< 40 s)
Number of subjects: 389

Group type: COMPARATOR
Intervention: Delayed cord clamping (DCC) (1-2 min)
Number of subjects: 389

Group type: COMPARATOR
Intervention: Cord milking (CM) (4 times towards the neonate)
Number of subjects: 389

Group type: COMPARATOR
Intervention: Cord milking (CM)
Number of subjects: 389

Group type: COMPARATOR
Intervention: Delayed cord clamping (DCC)
Number of subjects: 389

Group type: COMPARATOR
Intervention: Early cord clamping (ECC)
Number of subjects: 389
Study: 35576073

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg once daily for 3 months or until stone free
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo once daily for 3 months or until stone free
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tamsulosin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33838898

Group type: EXPERIMENTAL
Intervention: Early enteral feeding (EEN)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control (traditional feeding)
Number of subjects: 156
Study: 34999377

Group type: EXPERIMENTAL
Intervention: Combined non-pharmacological interventions (periodic reorientation, cognitive stimulation, correction of sensory deficits, environmental management, sleep promotion)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Combined non-pharmacological interventions
Number of subjects: 144
Study: 32918768

Group type: EXPERIMENTAL
Intervention: Dry immersion (DI) for 5 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 20
Study: 35848977

Group type: EXPERIMENTAL
Intervention: CHEP + TQABC
Number of subjects: 500

Group type: COMPARATOR
Intervention: CHEP formula placebo + TQABC formula placebo
Number of subjects: 500
Study: 33804348

Group type: EXPERIMENTAL
Intervention: Transcendental Meditation (TM)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control
Number of subjects: 45
Study: 32870318

Group type: EXPERIMENTAL
Intervention: Isokinetic training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sensory motor training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60

Group type: COMPARATOR
Intervention: Isokinetic training, Sensory motor training, Control
Number of subjects: 60
Study: 34715934

Group type: EXPERIMENTAL
Intervention: 5 mg/day ergothioneine for 12 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 30 mg/day ergothioneine for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 0
Study: 32726103

Group type: EXPERIMENTAL
Intervention: Iron-oxide containing formulations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mineral SPF 50+ sunscreen
Number of subjects: 0
Study: 33200891

Group type: EXPERIMENTAL
Intervention: Sotagliflozin
Number of subjects: 10584

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10584
Study: 32086888

Group type: EXPERIMENTAL
Intervention: Zhuyuan soup combined with fumigation and oral administration
Number of subjects: 60

Group type: COMPARATOR
Intervention: Budesonide nasal spray (western medicine group)
Number of subjects: 60
Study: 32138561

Group type: EXPERIMENTAL
Intervention: nCPAP
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: HHHFNC
Number of subjects: 40
Study: 33610417

Group type: EXPERIMENTAL
Intervention: Bioelectrical Impedance Analysis (BIA) with a new predictive equation
Number of subjects: 315
Study: 32888318

Group type: EXPERIMENTAL
Intervention: Combined 0.01% atropine with orthokeratology (AOK)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Orthokeratology (OK)
Number of subjects: 53
Study: 34363518

Group type: EXPERIMENTAL
Intervention: Practice-based training program
Number of subjects: 62

Group type: COMPARATOR
Intervention: Theory-based training program
Number of subjects: 62
Study: 33861194

Group type: EXPERIMENTAL
Intervention: Adrenaline (1 mg)
Number of subjects: 8014

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8014
Study: 33551026

Group type: EXPERIMENTAL
Intervention: Introduction of allergenic solids from age 3 months alongside breast-feeding
Number of subjects: 1303

Group type: COMPARATOR
Intervention: Exclusively breast-fed infants (control group)
Number of subjects: 1303
Study: 36063792

Group type: EXPERIMENTAL
Intervention: Goal-directed care bundle of intensive blood pressure lowering, glycemic control, antipyrexia, and anticoagulation reversal treatment
Number of subjects: 8360

Group type: COMPARATOR
Intervention: Usual standard of care
Number of subjects: 8360
Study: 33414540

Group type: EXPERIMENTAL
Intervention: Mature desmoplastic reaction (N = 638)
Number of subjects: 991

Group type: EXPERIMENTAL
Intervention: Intermediate desmoplastic reaction (N = 294)
Number of subjects: 991

Group type: EXPERIMENTAL
Intervention: Immature desmoplastic reaction (N = 59)
Number of subjects: 991

Group type: EXPERIMENTAL
Intervention: DR classification
Number of subjects: 991

Group type: EXPERIMENTAL
Intervention: DR categorisation
Number of subjects: 991
Study: 32579229

Group type: EXPERIMENTAL
Intervention: Simulation-based interprofessional education
Number of subjects: 29

Group type: COMPARATOR
Intervention: Online interprofessional education
Number of subjects: 29
Study: 35877385

Group type: EXPERIMENTAL
Intervention: Nomogram prediction model based on age, PI-RADS v2.1, and CEUS
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Nomogram prediction model
Number of subjects: 490
Study: 32981468

Group type: EXPERIMENTAL
Intervention: Concurrent complex training (CPX)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Heavy strength training (HST)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Endurance-strength training (EST)
Number of subjects: 38
Study: 35658775

Group type: EXPERIMENTAL
Intervention: Opt-out group (assigned an individual appointment)
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Opt-in group (invited to set an appointment)
Number of subjects: 2000
Study: 34856568

Group type: EXPERIMENTAL
Intervention: Postpartum PTSD symptoms assessed by TES (Traumatic Event Scale)
Number of subjects: 3891

Group type: EXPERIMENTAL
Intervention: Postpartum PTSD provisional diagnosis assessed by IES‐R (Impact of Event Scale‐Revised)
Number of subjects: 3891

Group type: EXPERIMENTAL
Intervention: Postpartum PTSD provisional diagnosis assessed by TES
Number of subjects: 3891

Group type: EXPERIMENTAL
Intervention: Risk factors associated with PTSD symptoms
Number of subjects: 3891
Study: 32270496

Group type: COMPARATOR
Intervention: 500 mL crystalloid fluid bolus over 30 minutes
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: 2-hour follow-up without interventions
Number of subjects: 130
Study: 35279277

Group type: EXPERIMENTAL
Intervention: Sevoflurane anaesthesia (n=14)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Propofol anaesthesia (n=13)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both anaesthesia types
Number of subjects: 27
Study: 616593029

Group type: EXPERIMENTAL
Intervention: Individual cognitive behavioral therapy (ICBT) program
Number of subjects: 91
Study: 36306989

Group type: EXPERIMENTAL
Intervention: Single developing lines
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Double developing lines
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (no developing lines)
Number of subjects: 240
Study: 34519717

Group type: EXPERIMENTAL
Intervention: Aerobic exercise that expended 20 kcal per kilogram of weight per week (20 KKW)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Aerobic exercise that expended 8 kcal/kg of body weight per week (8 KKW)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Healthy living control group
Number of subjects: 42
Study: 32334602

Group type: EXPERIMENTAL
Intervention: Benzodiazepines or z-hypnotics dispensed
Number of subjects: 10371

Group type: EXPERIMENTAL
Intervention: Gabapentinoids dispensed
Number of subjects: 10371

Group type: EXPERIMENTAL
Intervention: Mean daily dose of benzodiazepines or z-hypnotics
Number of subjects: 10371

Group type: EXPERIMENTAL
Intervention: Mean daily dose of pregabalin
Number of subjects: 10371

Group type: EXPERIMENTAL
Intervention: Association of gabapentinoids with benzodiazepines or z-hypnotics
Number of subjects: 10371

Group type: EXPERIMENTAL
Intervention: Association of non-OAT opioids with benzodiazepines or z-hypnotics
Number of subjects: 10371

Group type: EXPERIMENTAL
Intervention: Discontinuing OAT
Number of subjects: 10371
Study: 34330073

Group type: EXPERIMENTAL
Intervention: IVRS-based mHealth intervention
Number of subjects: 286
Study: 32560926

Group type: EXPERIMENTAL
Intervention: ICD-11 guidelines
Number of subjects: 1717

Group type: COMPARATOR
Intervention: ICD-10 guidelines
Number of subjects: 1717
Study: 34757704

Group type: EXPERIMENTAL
Intervention: Cold spinal mud pack (CSMP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Prone rest
Number of subjects: 100
Study: 34490179

Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA)
Number of subjects: 2166

Group type: EXPERIMENTAL
Intervention: Cardiorespiratory fitness (CRF)
Number of subjects: 2166

Group type: EXPERIMENTAL
Intervention: Sedentary behavior
Number of subjects: 2166
Study: 35998897

Group type: EXPERIMENTAL
Intervention: Calanus oil (2 g/day)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 34700446

Group type: EXPERIMENTAL
Intervention: High-dose treatment arm (74 Gy)
Number of subjects: 488

Group type: COMPARATOR
Intervention: Low-dose treatment arm (60 Gy)
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Dose to cardiac sub-regions
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Mean lung dose
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Log tumor volume
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Heart v5 and v30
Number of subjects: 488
Study: 35897470

Group type: EXPERIMENTAL
Intervention: Intermittent Hypoxic Training (IHE) group (n = 12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Intermittent Normoxia group (NA) (n = 12)
Number of subjects: 24